We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Intramedullary Implant System Stabilizes Fractures

By HospiMedica International staff writers
Posted on 09 Feb 2014
An innovative patient-specific orthopedic implant system aids in the stabilization and treatment of bone fractures.

The minimally invasive Photodynamic Bone Stabilization System (PBSS) is intended for the setting of bone fractures in light to low-load bearing indications, enabling clinicians to repair the fracture after alignment without the need for traditional metal hardware. More...
The PBSS implant is shaped only once it is inside the intramedullary space and has conformed to bone anatomy. The implant’s dimensions are determined by the bone canal itself, and the polymer never touches the bone and does not require any kind of direct bonding. The system is comprised of three items; a single use disposable procedure pack, a reusable light source, and procedure specific surgical instruments.

The procedure is performed through a minimal percutaneous surgical approach, through which the surgeon introduces the balloon catheter into the medullary canal transiting the fracture site. Once the fracture is aligned, the surgeon inflates the balloon with the liquid polymer and then exposes the liquid to the light. After light is applied to the liquid monomer in the balloon, it takes only minutes for it to completely harden and provide stabilization inside the bone. The PBSS is a product of IlluminOss Medical (East Providence, RI, USA), and has received the European Community marking of approval.

“We look forward to expanding access to this technology, which can significantly enhance how orthopedic fractures are treated,” said Dirk Kuyper, president and CEO of IlluminOss. “We are now commercially available in eight countries, providing patients and surgeons with an innovative and unprecedented fracture repair system.”

“With the IlluminOss system, I was able to stabilize the fibula using a small incision without disturbing the ankle joint or the skin surrounding the fracture. I was able to treat the patient in less than forty minutes and am totally satisfied with the result,” said Thomas Gausepohl, MD, a trauma surgeon in Germany who performed the first implant. “The patient did not need an external plaster cast to walk after the procedure. My continued and expanded use of the technology reinforces my belief that this is the beginning of a new era in fracture repair and fixation. Customized, minimally invasively formed implants will be the future of orthopedics.”

Related Links:

IlluminOss Medical



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.